Mauna Kea Technologies SA (FRA:1MK)

Market Cap	13.47M +8.8%
Revenue (ttm)	8.18M +0.3%
Net Income	-10.39M
EPS	-0.14
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3,732
Open	0.1332
Previous Close	0.1162
Day's Range	0.1332 - 0.1332
52-Week Range	0.0423 - 0.1966
Beta	n/a
RSI	67.37
Earnings Date	Apr 9, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporat...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 61
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1MK

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.